Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Porphyrins as new endogenous anti-inflammatory agents.
Jelić D, Tatić I, Trzun M, Hrvačić B, Brajša K, Verbanac D, Tomašković M, Čulić O, Antolović R, Glojnarić I, Weygand-Đurašević I, Vladimir-Knežević S, Mildner B. Jelić D, et al. Among authors: culic o. Eur J Pharmacol. 2012 Sep 15;691(1-3):251-60. doi: 10.1016/j.ejphar.2012.05.049. Epub 2012 Jun 9. Eur J Pharmacol. 2012. PMID: 22687816
Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects.
Culić O, Eraković V, Cepelak I, Barisić K, Brajsa K, Ferencić Z, Galović R, Glojnarić I, Manojlović Z, Munić V, Novak-Mircetić R, Pavicić-Beljak V, Sucić M, Veljaca M, Zanić-Grubisić T, Parnham MJ. Culić O, et al. Eur J Pharmacol. 2002 Aug 30;450(3):277-289. doi: 10.1016/s0014-2999(02)02042-3. Eur J Pharmacol. 2002. PMID: 12208321 Clinical Trial.
Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.
Parnham MJ, Culić O, Eraković V, Munić V, Popović-Grle S, Barisić K, Bosnar M, Brajsa K, Cepelak I, Cuzić S, Glojnarić I, Manojlović Z, Novak-Mircetić R, Oresković K, Pavicić-Beljak V, Radosević S, Sucić M. Parnham MJ, et al. Among authors: culic o. Eur J Pharmacol. 2005 Jul 4;517(1-2):132-43. doi: 10.1016/j.ejphar.2005.05.023. Eur J Pharmacol. 2005. PMID: 15964564 Clinical Trial.
Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta.
Bosnar M, Bosnjak B, Cuzic S, Hrvacic B, Marjanovic N, Glojnaric I, Culic O, Parnham MJ, Erakovic Haber V. Bosnar M, et al. Among authors: culic o. J Pharmacol Exp Ther. 2009 Oct;331(1):104-13. doi: 10.1124/jpet.109.155838. Epub 2009 Jul 24. J Pharmacol Exp Ther. 2009. PMID: 19633061
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M, Kragol G, Koštrun S, Vujasinović I, Bošnjak B, Bencetić Mihaljević V, Marušić Ištuk Z, Kapić S, Hrvačić B, Brajša K, Tavčar B, Jelić D, Glojnarić I, Verbanac D, Culić O, Padovan J, Alihodžić S, Eraković Haber V, Spaventi R. Bosnar M, et al. Among authors: culic o. J Med Chem. 2012 Jul 12;55(13):6111-23. doi: 10.1021/jm300356u. Epub 2012 Jun 25. J Med Chem. 2012. PMID: 22697905
Anti-inflammatory effects of macrolide antibiotics.
Culić O, Eraković V, Parnham MJ. Culić O, et al. Eur J Pharmacol. 2001 Oct 19;429(1-3):209-29. doi: 10.1016/s0014-2999(01)01321-8. Eur J Pharmacol. 2001. PMID: 11698042 Review.
34 results